Episode Details
Back to EpisodesAmerican Society of Hematology Annual Meeting 2024 – Updates in CLL (Part 1)
Episode 450
Published 1 year, 7 months ago
Description
Mazyar Shadman, MD, MPH and Catherine C. Coombs, MD review CLL abstracts presented at the ASH 2024 annual meeting, including results from the BRUIN CLL‑321 study of pirtobrutinib in relapsed or refractory CLL and the AMPLIFY study of first‑line acalabrutinib plus venetoclax.